nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—RRM2—G1/S-Specific Transcription—TYMS—rectum cancer	0.0386	0.0756	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.0344	0.0674	CbGpPWpGaD
Clofarabine—POLA1—seminal vesicle—rectum cancer	0.0328	0.0671	CbGeAlD
Clofarabine—RRM2—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.0284	0.0555	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TYMS—rectum cancer	0.0276	0.054	CbGpPWpGaD
Clofarabine—DCK—Pyrimidine metabolism—TYMS—rectum cancer	0.0274	0.0536	CbGpPWpGaD
Clofarabine—POLA1—G1/S-Specific Transcription—TYMS—rectum cancer	0.0264	0.0517	CbGpPWpGaD
Clofarabine—RRM1—seminal vesicle—rectum cancer	0.0261	0.0533	CbGeAlD
Clofarabine—POLA1—urethra—rectum cancer	0.026	0.0531	CbGeAlD
Clofarabine—RRM2—renal system—rectum cancer	0.0253	0.0517	CbGeAlD
Clofarabine—POLA1—mammalian vulva—rectum cancer	0.0247	0.0506	CbGeAlD
Clofarabine—RRM2—mammalian vulva—rectum cancer	0.0236	0.0483	CbGeAlD
Clofarabine—RRM2—Fluoropyrimidine Activity—TYMS—rectum cancer	0.0227	0.0444	CbGpPWpGaD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—TYMS—rectum cancer	0.0227	0.0444	CbGpPWpGaD
Clofarabine—RRM1—smooth muscle tissue—rectum cancer	0.0218	0.0446	CbGeAlD
Clofarabine—RRM1—renal system—rectum cancer	0.021	0.0429	CbGeAlD
Clofarabine—RRM1—urethra—rectum cancer	0.0206	0.0422	CbGeAlD
Clofarabine—RRM2—female reproductive system—rectum cancer	0.0202	0.0414	CbGeAlD
Clofarabine—DCK—seminal vesicle—rectum cancer	0.0202	0.0414	CbGeAlD
Clofarabine—RRM1—mammalian vulva—rectum cancer	0.0196	0.0402	CbGeAlD
Clofarabine—POLA1—vagina—rectum cancer	0.0192	0.0392	CbGeAlD
Clofarabine—RRM2—vagina—rectum cancer	0.0183	0.0374	CbGeAlD
Clofarabine—RRM1—female reproductive system—rectum cancer	0.0168	0.0344	CbGeAlD
Clofarabine—DCK—urethra—rectum cancer	0.016	0.0328	CbGeAlD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—rectum cancer	0.0155	0.0304	CbGpPWpGaD
Clofarabine—DCK—mammalian vulva—rectum cancer	0.0153	0.0312	CbGeAlD
Clofarabine—RRM1—vagina—rectum cancer	0.0152	0.0311	CbGeAlD
Clofarabine—RRM1—E2F transcription factor network—TYMS—rectum cancer	0.0146	0.0286	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide metabolism—TYMS—rectum cancer	0.0139	0.0271	CbGpPWpGaD
Clofarabine—DCK—female reproductive system—rectum cancer	0.0131	0.0267	CbGeAlD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.0127	0.0249	CbGpPWpGaD
Clofarabine—POLA1—lymph node—rectum cancer	0.0124	0.0253	CbGeAlD
Clofarabine—RRM2—E2F transcription factor network—TYMS—rectum cancer	0.012	0.0235	CbGpPWpGaD
Clofarabine—RRM2—lymph node—rectum cancer	0.0118	0.0242	CbGeAlD
Clofarabine—DCK—vagina—rectum cancer	0.0118	0.0242	CbGeAlD
Clofarabine—RRM2—Nucleotide metabolism—TYMS—rectum cancer	0.0114	0.0223	CbGpPWpGaD
Clofarabine—ABCG2—seminal vesicle—rectum cancer	0.0113	0.0231	CbGeAlD
Clofarabine—DCK—Nucleotide metabolism—TYMS—rectum cancer	0.0107	0.0209	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.0106	0.0208	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.0105	0.0205	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.0104	0.0203	CbGpPWpGaD
Clofarabine—RRM1—lymph node—rectum cancer	0.00984	0.0201	CbGeAlD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00977	0.0191	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—RAB1A—rectum cancer	0.00951	0.0186	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RAB1A—rectum cancer	0.00929	0.0182	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—rectum cancer	0.00914	0.0179	CbGpPWpGaD
Clofarabine—ABCG2—urethra—rectum cancer	0.00894	0.0183	CbGeAlD
Clofarabine—RRM2—G1/S Transition—TYMS—rectum cancer	0.00873	0.0171	CbGpPWpGaD
Clofarabine—ABCG2—mammalian vulva—rectum cancer	0.00851	0.0174	CbGeAlD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00849	0.0166	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—TYMS—rectum cancer	0.00823	0.0161	CbGpPWpGaD
Clofarabine—DCK—lymph node—rectum cancer	0.00764	0.0156	CbGeAlD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—rectum cancer	0.00753	0.0147	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.00736	0.0144	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00715	0.014	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00711	0.0139	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00677	0.0132	CbGpPWpGaD
Clofarabine—ABCG2—vagina—rectum cancer	0.00659	0.0135	CbGeAlD
Clofarabine—POLA1—Cell Cycle—RAB1A—rectum cancer	0.00636	0.0124	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—TYMS—rectum cancer	0.00597	0.0117	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.00503	0.00985	CbGpPWpGaD
Clofarabine—ABCG2—lymph node—rectum cancer	0.00426	0.00872	CbGeAlD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00421	0.00824	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00381	0.00746	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00347	0.00679	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00324	0.00634	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00302	0.00592	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—rectum cancer	0.00282	0.00551	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—TYMS—rectum cancer	0.0027	0.00528	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.00253	0.00494	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TYMS—rectum cancer	0.00241	0.00472	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00237	0.00464	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.00224	0.00439	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—TYMS—rectum cancer	0.00185	0.00361	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TYMS—rectum cancer	0.00165	0.00323	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.00142	0.00278	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.00126	0.00247	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—TYMS—rectum cancer	0.00126	0.00246	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TYMS—rectum cancer	0.00104	0.00203	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TYMS—rectum cancer	0.000968	0.0019	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—rectum cancer	0.0008	0.00157	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—rectum cancer	0.000547	0.00107	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TYMS—rectum cancer	0.000388	0.000759	CbGpPWpGaD
